Evidence map›Paper›PMID 39498006›Full record

ArticleHeliyon2024

Coexistence of DIPNECH with pulmonary adenocarcinoma: Coincidence or by design?

Xiaoyu Song, Qinghua Cao, Wei Liu, Yanan Zhang, Junmei Hao

Abstract readCase Reports
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoyu SongDepartment of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong Province, 264100, China.
Qinghua CaoDepartment of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong Province, 264100, China.
Wei LiuDepartment of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong Province, 264100, China.
Yanan ZhangDepartment of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong Province, 264100, China.
Junmei HaoDepartment of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong Province, 264100, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) coexisting with pulmonary adenocarcinoma (ADC) is rare. Herein, we report a new case and review the cases published previously in the English literature. The clinicopathological features of similar cases reported in the English literature were summarized, and a putative association between DIPNECH and pulmonary ADC was suggested. Among the 22 cases studied, the majority of patients were female and older adults. DIPNECH lesions were usually recognized beyond the lobe or segment in which the ADC was located. Most ADCs were of a low- or intermediate-grade. DIPNECH and pulmonary ADC were interspersed in six patients. In particular, two cases of ADC showed neuroendocrine differentiation. We consider that DIPNECH accompanied by ADC is not coincidental, and that the two lesions may have a causal relationship. Analogous to the tumor histogenesis association of large cell neuroendocrine carcinoma/small cell carcinoma with ADC, we hypothesized that DIPNECH may also arise from a multipotent precursor cell and associate with a subgroup of ADC. However, further studies are required to explore this possibility.

Indexed as

Case reportClinicopathological featuresDiffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)Pulmonary adenocarcinoma (ADC)

Identifiers

PMID39498006
PMCPMC11534178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.